Watch XVIVO’s Capital Markets Day 2022 on-demand.
Founded in 1998, XVIVO is the only medical technology company
dedicated to extending the life of all major organs – so transplant teams around the world can save more lives. Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine.
XVIVO is the forerunner in life-extending technologies for organs. We lead the way by following the science.
Clinically optimized solutions for organ, tissue and cell preservation and perfusion in connection with transplantation.Find out more
Devices for oxygenated machine perfusion during preconditioning, preservation, reconditioning and transport of organs.Find out more
XVIVO offers dedicated surgical teams responsible for the recovery of donor organs and for transporting them to transplantation clinics where the implantation surgery is performed by the clinic’s own surgeons.Find out more
The Annual Report is available in pdf format and in ESEF format (European Single Electronic Format) and is also available at www.xvivoperfusion.com.
A printed version of the Annual Report 2020 can be ordered by phone +46 (0) 31 788 21 50 or by email firstname.lastname@example.org.
Watch XVIVO's Capital Markets Day 2022 on-demand.